Back to search

Article

Circulating levels of epirubicin cause endothelial senescence while compromising metabolic activity and vascular function

2020-06-26

Abstract excerpt

Anthracycline-based chemotherapy is a common treatment for cancer patients. Because it is delivered intravenously, endothelial cells are exposed first and to the highest concentrations, prior to diffusion to target cells. Not surprisingly, vascular dysfunction is a consequence of anthracycline therapy. While chemotherapy-induced endothelial damage at administration sites has been investigated, the effects of lower...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work
1e990393-f7e8-54c3-9fb4-a5fec0e6e905
DOI
10.1101/2020.06.25.171249
Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest
Interactive article relationship graphSelect a related publication card to move it into the centre and load its closest explainable connections. Solid lines are source-backed structured connections. Dashed lines are semantic discovery signals and are not scientific evidence.
Circulating levels of epirubicin cause endothelial senescence while compromising metabolic activity and vascular functionDOI 10.1101/2020.06.25.171249
Select a neighboring publication to make it the new centre.